Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
33.98
-1.12 (-3.19%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Capricor Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-105.04-40.47-22.29-29.02-20.02
Upgrade
Depreciation & Amortization
1.891.431.070.530.25
Upgrade
Loss (Gain) From Sale of Assets
0.160.110.010.030.01
Upgrade
Stock-Based Compensation
17.239.777.394.462.97
Upgrade
Other Operating Activities
3.76-0.05-0.020.16-0.27
Upgrade
Change in Accounts Receivable
10.310-9.82-0.16-0.39
Upgrade
Change in Accounts Payable
5.981.941.331.210.99
Upgrade
Change in Unearned Revenue
--12.27-3.1827.45-
Upgrade
Change in Other Net Operating Assets
-4.09-0.46-0.080.25-0.34
Upgrade
Operating Cash Flow
-69.81-40-25.64.92-16.81
Upgrade
Capital Expenditures
-11.72-1.54-2.05-3.36-1.2
Upgrade
Investment in Securities
109.2-114.647.16-31.71-
Upgrade
Investing Cash Flow
97.48-116.185.11-35.07-1.2
Upgrade
Issuance of Common Stock
248.89152.7725.584.8720.23
Upgrade
Financing Cash Flow
248.89152.7725.584.8720.23
Upgrade
Net Cash Flow
276.56-3.415.09-25.282.22
Upgrade
Free Cash Flow
-81.54-41.53-27.641.56-18.01
Upgrade
Free Cash Flow Margin
--186.50%-109.79%61.02%-7352.29%
Upgrade
Free Cash Flow Per Share
-1.75-1.18-1.030.06-0.78
Upgrade
Cash Income Tax Paid
00---
Upgrade
Levered Free Cash Flow
-39.6-27.78-10.922.34-10.62
Upgrade
Unlevered Free Cash Flow
-37.7-27.78-10.922.34-10.62
Upgrade
Change in Working Capital
12.2-10.78-11.7528.750.26
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.